Connect for Cancer Prevention Study
The Connect for Cancer Prevention Study wants to better understand the causes of cancer and how to prevent it. Kaiser Permanente Hawaii (KPHI) is one of nine health care systems throughout the country to partner with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), for Connect. The study will include 200,000 adults who get their health care from a partner health care system, are between 40 and 65 years old at enrollment, and have never had cancer. People who have or once had non-melanoma skin cancer, or a condition that raises the risk of getting cancer (such as DCIS, or stage 0 breast cancer), can still join.
Participants will be asked to answer online health surveys, donate samples of blood, urine, and saliva, and share access to their electronic health records. This information will help researchers study the health and behavior patterns that may affect cancer risk. It takes time to understand the causes of cancer, so Connect will go on for many years. The longer you participate, the more we may learn.
Find Connect on clinicaltrials.gov
Kaiser Permanente Research Bank
The Kaiser Permanente Research Bank is a collection of health information and blood samples shared by volunteers like you. This information helps doctors and researchers discover ways to help people live healthier lives. Many members join the Research Bank with the hope that sharing their information will help find solutions for an illness that affects their family.
For questions and to learn more, call us at: 1-844-268-2947
To join, visit us at kp.org/researchbank
Oncology clinical trials are offered as options for the treatment of cancer. We handle pharmacy, regulatory, and patient related activities locally for pharmaceutical industry studies. We also have access to cooperative group studies as an integral part of the Kaiser Permanente National Cancer Institute (NCI) Community Oncology Research Program (NCORP) consortium. We work with pharmaceutical industry leaders who are testing novel agents and require further testing and data, to support applications for approval to the Food & Drug Administration (FDA). All study investigators and providers, including our nursing and pharmacy staff, are trained and certified for their role on these clinical trials. Our oncology patients have an opportunity to voluntarily enroll in these studies provided they meet specific enrollment conditions. Kaiser Permanente is proud to be recognized as a national leader in clinical trials enrollment and contributions to the scientific community at large.
For more information, please visit http://research.kphawaii.org/oncology-research-program